Rezvilutamide not checked

Hengrui · SHR3680

FollowEvery change as it happens, and a Monday email
Stage
in China
Next date
Phase 3 trial completes
Trials
3 active
12 in total · 1 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Prostate Cancer (2 trials), Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Main trialPhase 3
“This study aims to compare the efficacy and safety of rezvilutamide with enzalutamide in the treatment of patients with low-volume metastatic hormone sensitive prostate cancer.”In the company’s words, NCT07241416 on ClinicalTrials.gov
Other names
SHR3680

Other drugs for Prostate Cancer

All 194 drugs for Prostate Cancer

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials12

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Mar 2027 A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 2Recruiting Dec 2028 A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
Phase 1/2Recruiting Nov 2027 A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Phase 3Unknown 30 Apr 2023 A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Phase 3Terminated 6 Sep 2024 A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy
Phase 2Terminated 31 Aug 2021 A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC
Phase 2Unknown 1 Oct 2022 A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC
Phase 1/2Terminated 30 Sep 2019 A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC
Phase 1Unknown 15 Mar 2021 Relative Bioavailability Study of SHR3680
Phase 1Completed 8 Sep 2021 Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
Phase 1Unknown Jul 2023 An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants
Phase 1Unknown 5 Nov 2024 A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Rezvilutamide

Following is part of Solo: you see every change to Rezvilutamide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in